Recently, we demonstrated that the recombinant S. mansoni antigens Sm29 SmTSP-2, and also PIII down-modulated the production of IFN-γ and TNF in a group of cutaneous leishmaniasis (CL) patients [8]. This evidence concerns the gene IFNG and cutaneous leishmaniasis.